43 related articles for article (PubMed ID: 1849504)
1. [Role of high-dose chemotherapy with hemopoietic stem-cell support in the treatment of adult patients with high-grade glioma].
Linassier C; Destrieux C; Benboubker L; Alcaraz L; Bergemer-Fouquet AM; Jan M; Calais G; Colombat P
Bull Cancer; 2001 Sep; 88(9):871-6. PubMed ID: 11604360
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy of malignant gliomas: studies of the BTCG.
Shapiro WR
Rev Neurol (Paris); 1992; 148(6-7):428-34. PubMed ID: 1448662
[TBL] [Abstract][Full Text] [Related]
3. Cisplatin and etoposide combination therapy for primary glial tumors: preliminary results.
Boiardi A; Silvani A; Milanesi I; Munari L; Solero CL; Botturi M
Ital J Neurol Sci; 1991 Feb; 12(1):33-7. PubMed ID: 1849504
[TBL] [Abstract][Full Text] [Related]
4. Preliminary data by cis-platin and etoposide using in primary glioblastoma.
Milanesi I; Silvani A; Munari L; Solero CL; Botturi M; Boiardi A
J Neurosurg Sci; 1990; 34(3-4):279-82. PubMed ID: 1965906
[TBL] [Abstract][Full Text] [Related]
5. Hyperfractionated radiation therapy (HFX RT) followed by multiagent chemotherapy (CHT) in patients with malignant glioma: a phase II study.
Jeremic B; Grujicic D; Antunovic V; Djuric L; Stojanovic M; Shibamoto Y
Int J Radiat Oncol Biol Phys; 1994 Dec; 30(5):1179-85. PubMed ID: 7961028
[TBL] [Abstract][Full Text] [Related]
6. Concurrent accelerated hyperfractionated radiation therapy and carboplatin/etoposide in patients with malignant glioma: long-term results of a phase II study.
Jeremic B; Shibamoto Y; Grujicic D; Stojanovic M; Milicic B; Nikolic N; Dagovic A; Aleksandrovic J
J Neurooncol; 2001 Jan; 51(2):133-41. PubMed ID: 11386410
[TBL] [Abstract][Full Text] [Related]
7. Phase I and pharmacokinetic study of preirradiation chemotherapy with BCNU, cisplatin, etoposide, and accelerated radiation therapy in patients with high-grade glioma.
Rajkumar SV; Buckner JC; Schomberg PJ; Reid JM; Bagniewski PJ; Ames MM; Cascino TL; Marks RS
Int J Radiat Oncol Biol Phys; 1998 Dec; 42(5):969-75. PubMed ID: 9869217
[TBL] [Abstract][Full Text] [Related]
8. Treatment of newly diagnosed glioblastoma multiforme with carmustine, cisplatin and etoposide followed by radiotherapy. A phase II study.
Lassen U; Kristjansen PE; Wagner A; Kosteljanetz M; Poulsen HS
J Neurooncol; 1999 Jun; 43(2):161-6. PubMed ID: 10533728
[TBL] [Abstract][Full Text] [Related]
9. Cisplatin therapy in recurrent childhood brain tumors.
Khan AB; D'Souza BJ; Wharam MD; Champion LA; Sinks LF; Woo SY; McCullough DC; Leventhal BG
Cancer Treat Rep; 1982 Dec; 66(12):2013-20. PubMed ID: 6890409
[TBL] [Abstract][Full Text] [Related]
10. Etoposide (VP-16-213) in malignant brain tumors: a phase II study.
Tirelli U; D'Incalci M; Canetta R; Tumolo S; Franchin G; Veronesi A; Galligioni E; Trovò MG; Rossi C; Grigoletto E
J Clin Oncol; 1984 May; 2(5):432-7. PubMed ID: 6726296
[TBL] [Abstract][Full Text] [Related]
11. Penetration of VP-16 (etoposide) into human intracerebral and extracerebral tumors.
Stewart DJ; Richard MT; Hugenholtz H; Dennery JM; Belanger R; Gerin-Lajoie J; Montpetit V; Nundy D; Prior J; Hopkins HS
J Neurooncol; 1984; 2(2):133-9. PubMed ID: 6481426
[TBL] [Abstract][Full Text] [Related]
12. A randomized comparison of misonidazole sensitized radiotherapy plus BCNU and radiotherapy plus BCNU for treatment of malignant glioma after surgery; preliminary results of an RTOG study.
Nelson DF; Schoenfeld D; Weinstein AS; Nelson JS; Wasserman T; Goodman RL; Carabell S
Int J Radiat Oncol Biol Phys; 1983 Aug; 9(8):1143-51. PubMed ID: 6347995
[TBL] [Abstract][Full Text] [Related]
13. Superfractionation in glioblastoma multiforme--results of a phase II study.
Douglas BG; Worth AJ
Int J Radiat Oncol Biol Phys; 1982 Oct; 8(10):1787-94. PubMed ID: 6295986
[TBL] [Abstract][Full Text] [Related]
14. Malignant astrocytoma: hyperfractionated and standard radiotherapy with chemotherapy in a randomized prospective clinical trial.
Payne DG; Simpson WJ; Keen C; Platts ME
Cancer; 1982 Dec; 50(11):2301-6. PubMed ID: 6291739
[TBL] [Abstract][Full Text] [Related]
15. Misonidazole combined with hyperfractionation in the management of malignant glioma.
Fulton DS; Urtasun RC; Shin KH; Geggie PH; Thomas H; Muller PJ; Moody J; Tanasichuk H; Mielke B; Johnson E
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1709-12. PubMed ID: 6090367
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]